BridgeBio Pharma Inc (BBIO) — Financial Flexibility Index
BridgeBio Pharma Inc (BBIO) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of $-109.10 Million (operating CF $-109.57 Million minus capex $470.00K) represents 0% of total liabilities ($2.92 Billion). Also explore BridgeBio Pharma Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BridgeBio Pharma Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for BridgeBio Pharma Inc across 8 annual periods. Check BBIO capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BridgeBio Pharma Inc (2017–2024)
Year-by-year free cash flow to debt coverage for BridgeBio Pharma Inc. For the full company profile including market capitalisation, see how much is BridgeBio Pharma Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.22x | $-519.79 Million | $-520.73 Million | $2.38 Billion | ▲ +21.5% |
| 2023 | -0.28x | $-526.41 Million | $-527.72 Million | $1.89 Billion | ▼ -26.0% |
| 2022 | -0.22x | $-413.17 Million | $-419.49 Million | $1.87 Billion | ▲ +7.6% |
| 2021 | -0.24x | $-449.69 Million | $-497.93 Million | $1.88 Billion | ▲ +63.6% |
| 2020 | -0.66x | $-392.20 Million | $-399.71 Million | $595.70 Million | ▲ +58.7% |
| 2019 | -1.60x | $-248.45 Million | $-253.59 Million | $155.70 Million | ▼ -663.0% |
| 2018 | -0.21x | $-118.47 Million | $-136.64 Million | $566.44 Million | ▲ +20.2% |
| 2017 | -0.26x | $-40.02 Million | $-40.49 Million | $152.73 Million | — |